Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06461403 · ClinicalTrials.gov registry record · NA

Inhaler Trainer Efficacy Study

A NA study of Asthma and COPD, sponsored by Koronis Biomedical Technologies.

Recruiting
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT06461403 is a NA study of Asthma and COPD that is actively recruiting participants, run by Koronis Biomedical Technologies. The registered enrollment target is 140 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06461403, a NA study of Asthma and COPD, is actively recruiting participants, sponsored by Koronis Biomedical Technologies.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

This will be a randomized, controlled, clinical trial. The investigators aim to determine the feasibility of and efficacy of the Inhaler Trainer Device for ongoing inhaler skill training. The research team will enroll 140 patients from the inpatient or outpatient setting from the University of Chicago Medicine over the course of up to 12 months. Participants will complete assessments, a lung function test via spirometry, and inhaler education via either the Inhaler Trainer Device learning program or Brief Intervention. All participants will return at 6 weeks (window of +/- one week) post-initial inhaler education for an in-person evaluation of their inhaler skills, lung function, and acute care utilization. Finally, a post-study semi-structured interview will be conducted to gather feedback on the device after the 6-week visit has been completed.

Interventions

  • DEVICE Inhaler Trainer System
  • OTHER Initial Inhaler Use Assessment
  • OTHER Inhaler Use Instruction

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2025-10-09
Est. Completion 2026-02-01
Phase NA

Sponsor

Koronis Biomedical Technologies

2 total trials

What the Registry Record Tells You About NCT06461403

The ClinicalTrials.gov registry entry for NCT06461403 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (91% lower). The listed sponsor is Koronis Biomedical Technologies, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which Inhaler Trainer System is the first listed.

NCT06461403 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06461403 about?

NCT06461403 is a clinical study titled "Inhaler Trainer Efficacy Study". This will be a randomized, controlled, clinical trial. The investigators aim to determine the feasibility of and efficacy of the Inhaler Trainer Device for ongoing inhaler skill training. The research team will enroll 140 patients from the inpatient or outpatient setting from the University of Chic...

What is the current status of trial NCT06461403?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2025-10-09. Estimated completion is 2026-02-01.

What conditions does trial NCT06461403 study?

This clinical trial studies the following conditions: Asthma, COPD, Acute Exacerbation of COPD.

What interventions are being tested in trial NCT06461403?

The interventions under investigation include: Inhaler Trainer System (DEVICE), Initial Inhaler Use Assessment (OTHER), Inhaler Use Instruction (OTHER).

Who is sponsoring clinical trial NCT06461403?

This trial is sponsored by Koronis Biomedical Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06461403 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.